{
  "folder": "IC-242",
  "content": "{{knowledge objective\n|Identifiant=OIC-242-13-B\n|Item_parent=Hyperthyroidism\n|Item_parent_short=Hyperthyroidism\n|Rank=B\n|Title=Knowing the principles of the therapeutic management of hyperthyroidism\n|Description=None\n|Rubric=Management\n|Contributors=Magalie Haissaguerre,Camille Buffet\n|Order=13}}\n\n\n\nThe majority of thyrotoxicoses can be treated on an outpatient basis following a consultation.\n\nYou need to know how to identify the rare emergency situations that require immediate treatment or even hospitalisation:\n\n- '''acute thyrotoxic crisis [[Hyperthermia/fever SD-044]] [[Tachycardia SD-166]] [[Diarrhoea SD-002]]''''\n\n- '''Cardiothyreosis''' in an elderly person or one with heart disease [[Palpitations SD-165]] [[Tachycardia SD-166]]\n\n- '''malignant orbitopathy''' [[Diplopia SD-143]]\n\n- ''cachectic form'' in elderly patients or those with another chronic disease\n\nTreatment of hyperthyroidism includes symptomatic treatment of thyrotoxicosis and specific treatment of hyperthyroidism.\n\n[Writing a prescription/medical letter SD-342|Explaining a treatment to a patient (adult/child/adolescent) SD-352]]\n\n[Explaining a treatment to a patient (adult/child/adolescent) SD-352]]\n\nSymptomatic treatments include :\n\n- rest\n\n- beta-blockers, in particular non-cardioselective beta-blockers (after eliminating any contraindications) to reduce tachycardia and tremors of the extremities\n\n- sedatives or benzodiazepines for behavioural problems such as agitation or incapacitating insomnia\n\nThe ''specific treatments for hyperthyroidism'' are :\n\n- synthetic antithyroid drugs, in combination with effective contraception and monitoring of hepatic and haematological tolerance\n\n- total thyroidectomy'' resulting in hypothyroidism, with definitive replacement\n\n- treatment with radioactive iodine, in the absence of contraindication (pregnancy; progressive or severe or very inflammatory orbitopathy)\n\n'''The choice of treatment depends on the cause of the hyperthyroidism'' (Basedow, toxic multinodular goitre, toxic adenoma or hyperthyroidism induced by iodine overload; thyroiditis) '''and the context'' (patient's age, patient's request, desire for pregnancy, drug tolerance).\n\nGraves' disease can occur as a single episode, but the risk of recurrence is 40-60% after well-managed treatment.\n\n'''In pregnant women:''''\n\n- Treatment of Graves' disease during pregnancy requires specialised management to discuss the indication for a low-dose synthetic antithyroid drug, to limit teratogenicity and to determine monitoring procedures, as spontaneous remissions are frequent in the second half of pregnancy.\n\n- The differential diagnosis to be aware of is transient gestational thyrotoxicosis, which is more common than Graves' disease in pregnancy (2% of pregnancies, negative TSH receptor antibodies and occasional hyperthyroidism in the 1st<sup> trimester of pregnancy).\n----",
  "question": {
    "question": "In the therapeutic management of hyperthyroidism, which factor does NOT influence the choice of treatment?",
    "option_a": "The presence of TSH receptor antibodies indicating Graves' disease",
    "option_b": "The patient's desire for pregnancy",
    "option_c": "The patient's preference for a specific treatment based on personal beliefs",
    "option_d": "The risk of recurrence of Graves' disease after treatment",
    "correct_option": "c"
  }
}